BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G Report for Lineage Cell Therapeutics Inc Common Stock (LCTX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lineage Cell Therapeutics Inc Common Stock
Symbol: LCTX
Shares outstanding: 229,066,100 shares
Disclosed Ownership: 11,453,305 shares
Ownership: 5%
Form type: SCHEDULE 13G
Filing time: 24 Apr 2025, 08:48:41 UTC
Date of event: 31 Mar 2025
Previous filing: 05 Feb 2025
Next filing: 17 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5%	11,453,305	11,393,041	0	Spencer Fleming	Managing Director